Abstract
Oligonucleotides are increasingly being used as a programmable connection material to assemble molecules and proteins in well-defined structures. For the application of such assemblies for in vivo diagnostics or therapeutics it is crucial that the oligonucleotides form highly stable, non-toxic, and non-immunogenic structures. Only few oligonucleotide derivatives fulfil all of these requirements. Here we report on the application of acyclic l-threoninol nucleic acid (aTNA) to form a four-way junction (4WJ) that is highly stable and enables facile assembly of components for in vivo treatment and imaging. The aTNA 4WJ is serum-stable, shows no non-targeted uptake or cytotoxicity, and invokes no innate immune response. As a proof of concept, we modify the 4WJ with a cancer-targeting and a serum half-life extension moiety and show the effect of these functionalized 4WJs in vitro and in vivo, respectively.
Original language | English |
---|---|
Article number | 202115275 |
Journal | Angewandte Chemie - International Edition |
Volume | 61 |
Issue | 24 |
Number of pages | 7 |
ISSN | 1433-7851 |
DOIs | |
Publication status | Published - Jun 2022 |
Keywords
- aTNA
- DNA
- Holliday Junction
- Nanostructures
- CELLS
- NANOBODIES
- DNA NANOSTRUCTURES
- PROTEINS
- DELIVERY
- Butylene Glycols
- Nucleic Acids/chemistry
- Oligonucleotides
- RNA/chemistry
- Amino Alcohols/chemistry
- Nucleic Acid Conformation